Strong target candidate with converging metabolic, structural and chemical evidence.
Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.
Main supporting evidence
Risks to review
Evidence coverage
Terms and data sources used on this page
PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.
AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.
ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.
pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.
FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.
Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.
PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.
ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.
ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.
LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.
Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.
DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.
Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.
EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.
KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.
Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.
Prioritization evidence
Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.
Off-target risk
- Human off-target
- Hit
- Human identity (%)
- 27.957 Lower values reduce human off-target concern.
- Human E-value
- 7.87e-06
- Gut microbiome similarity
- 1.7% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.
Essentiality
- Essential (DEG)
- N
- DEG identity (%)
- 39.362 Higher values support similarity to known essential genes.
Structure confidence
- ColabFold pLDDT
- 94.2 0-100 confidence; >70 supports local structural interpretation.
Binding-site evidence
PDB experimental structureP2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.
Sequence
Primary amino-acid sequence viewer.
MLSMEPCRGTPPQWRIFRQGLYTLEVDTRSGTPTMIISLEEKETSAAAPQIRQCPKWDGKPLTIDVSKTFAEGSKVRDFYSGNVATVSGGKITLQPAFGSNGLLLLERAETAAPAPFDWHNATVYFVLTDRFVNGNPANDNSYGRHKDGMQEIGTFHGGDLQGLTSKLDYLQQMGVNALWISSPLEQIHGWVGGGTKGDFPHYAYHGYYTQDWSKLDANMGTEADLRRLVDEAHKRGIRILFDVVMNHAGYATLADMQEFQFGSLYLQGDELKKTLGERWTDWKPGAGQTWHSFNDYINFSDKAGWEKWWGKKWIRTDIGDYDNPGYDDLTMSLAFLPDLKTESKEVSGLPNFYNHKPDTAAKAIPGYTPRDYLTHWLSQWVRDYGIDGFRVDTAKHVEMDAWQQLKTQATAALAEWKKANPDKALDAAPFWMTGEAWGHGVMQSDYYRHGFDAMINFDYQDQAAKAATCMANIDLTWQQMADKLQSFNVLSYLSSHDTRLFREGGTTAAELLLLAPGAVQIFYGDESSRPFGPTGSDPLQGTRSEMNWQDVNGKAARSVTHWQKIGQFRARHPAIGMGKQTTLSMPRGYGFVRESGEDKVMVIWAGQQQ
Functional annotations
Enzyme classification and Gene Ontology terms linked to this protein.
Subcellular localization
- Localization
- Periplasmic
Enzyme Commission (EC)
1Gene Ontology (GO)
7- GO:0005975 The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
- GO:0042597 The region between the inner (cytoplasmic) and outer membrane (Gram-negative Bacteria) or cytoplasmic membrane and cell wall (Fungi and Gram-positive Bacteria).
- GO:0004556 Catalysis of the endohydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides containing three or more alpha-(1->4)-linked D-glucose units.
- GO:0005509 Binding to a calcium ion (Ca2+).
- GO:0033927 Catalysis of the hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends.
- GO:0030980 The chemical reactions and pathways resulting in the breakdown of alpha-glucans.
- GO:0009313 The chemical reactions and pathways resulting in the breakdown of oligosaccharides, molecules with between two and (about) 20 monosaccharide residues connected by glycosidic linkages.
Sequence domains and features
Domain and signature matches imported from InterPro and related databases.
Show feature table
| Start | End | DB | Term | Name |
|---|---|---|---|---|
| 109 | 350 | Gene3D | G3DSA:3.20.20.80 | Glycosidases |
| 126 | 570 | SMART | SM00642 | aamy |
| 126 | 570 | InterPro | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| 109 | 348 | FunFam | G3DSA:3.20.20.80:FF:000089 | Periplasmic alpha-amylase |
| 112 | 579 | SUPERFAMILY | SSF51445 | (Trans)glycosidases |
| 112 | 579 | InterPro | IPR017853 | Glycoside hydrolase superfamily |
| 362 | 575 | FunFam | G3DSA:3.20.20.80:FF:000079 | Alpha-amylase |
| 109 | 604 | PANTHER | PTHR10357 | ALPHA-AMYLASE FAMILY MEMBER |
| 355 | 577 | Gene3D | G3DSA:3.20.20.80 | Glycosidases |
| 159 | 302 | Pfam | PF00128 | Alpha amylase, catalytic domain |
| 159 | 302 | InterPro | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| 373 | 527 | Pfam | PF00128 | Alpha amylase, catalytic domain |
| 373 | 527 | InterPro | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
3D structure
Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.
How colors and pocket overlays are used
Pocket details Inspect a specific pocket, or open the full viewer
- Method
- -
- Score
- -
- Visible layer
- -
- Residues
- -
- Pocket properties
- -
Selecting a pocket opens its details and centers the viewer without clearing other active layers. Use Focus this pocket when you want to hide the rest; use Surface for the wider residue environment.
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · P2Rank
Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2
Binding pockets · FPocket
Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4
Residue sets
All structural evidence
Structural evidence
4 + 1Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.
| Entry | Method | Resolution | Chain | Coverage | Links | Status |
|---|---|---|---|---|---|---|
|
PDB
9US3
|
X-ray | 1.90 Å | A,B |
|
Viewing | |
|
PDB
9US4
|
X-ray | 1.95 Å | A,B |
|
Loaded | |
|
PDB
9US6
|
X-ray | 2.70 Å | A,B |
|
Loaded | |
|
PDB
9US5
|
X-ray | 2.66 Å | A |
|
Loaded | |
|
ColabFold
VK055_3534
|
ColabFold | — | — | full sequence | — | Loaded |
Ligand evidence
Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.
Structural ligand evidence is available for this target.
Highest-confidence structural evidence: ligands co-crystallized with this exact protein. If the source PDB is loaded in Target, use Open crystal to inspect it in the structure viewer.
No PDB structure with a co-crystallized ligand found for this exact protein.
Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.
| Ligand | Source crystal | UniProt (homolog) | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|---|
| ABC RCSB PDB | P0C1B3 | 937.9 Da LogP -10.86 TPSA 439.0 | 3 viol. | ✓ Clean |
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@…
|
|
| ACI RCSB PDB | P43379 | 175.2 Da LogP -2.67 TPSA 106.9 | ✓ Ro5 | ✓ Clean |
C1=C([C@H]([C@@H]([C@H]([C@H]1N)O)O)O)CO
|
|
| ARE RCSB PDB | Q08751 | 807.7 Da LogP -10.74 TPSA 400.3 | 3 viol. | ✓ Clean |
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@…
|
|
| FLC RCSB PDB | U5CJP3 | 189.1 Da LogP -5.25 TPSA 140.6 | ✓ Ro5 | ✓ Clean |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
|
|
| NOJ RCSB PDB | P05618 | 163.2 Da LogP -2.97 TPSA 93.0 | ✓ Ro5 | ✓ Clean |
C1[C@@H]([C@H]([C@@H]([C@H](N1)CO)O)O)O
|
Experimental bioactivity from ChEMBL measured directly on this protein. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL bioactivity data found for this exact protein.
Bioactivity inferred from similar proteins in ChEMBL. Score = pchembl (−log Ki/IC₅₀; higher = more potent).
No ChEMBL hits found through similar proteins.
Proposed virtual-screening candidates from ZINC. Score = Tanimoto similarity to a known binder (0–1; higher = more similar).
| Ligand | Tanimoto | MW · LogP · TPSA | Lipinski | PAINS | SMILES |
|---|---|---|---|---|---|
| ZINC100055151 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](CO)O…
|
| ZINC100055153 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](CO)O…
|
| ZINC100055156 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H…
|
| ZINC100055157 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H…
|
| ZINC16123955 ZINC | 0.500 | 204.2 Da LogP -2.82 TPSA 101.8 | ✓ Ro5 | ✓ Clean |
CC(=O)NC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O
|
| ZINC2362797719 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3[C@@H](O)[C…
|
| ZINC55537584 ZINC | 0.500 | 488.4 Da LogP -6.55 TPSA 248.4 | 2 viol. | ✓ Clean |
C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@@H]3[C@@H](CO)…
|
PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.
Cross-references
External database identifiers for this protein, its structures, ligands, and metabolic reactions.